Cerro-Herreros, E., Núñez-Manchón, J., Naldaiz-Gastesi, N., Carrascosa-Sàez, M., García-Rey, A., Losilla, D., . . . Artero, R. (2024). AntimiR treatment corrects myotonic dystrophy primary cell defects across several CTG repeat expansions with a dual mechanism of action.
Citación estilo ChicagoCerro-Herreros, E., et al. AntimiR Treatment Corrects Myotonic Dystrophy Primary Cell Defects Across Several CTG Repeat Expansions With a Dual Mechanism of Action. 2024.
Cita MLACerro-Herreros, E., et al. AntimiR Treatment Corrects Myotonic Dystrophy Primary Cell Defects Across Several CTG Repeat Expansions With a Dual Mechanism of Action. 2024.
Precaución: Estas citas no son 100% exactas.